Fernando C. Fervenza

Active 2001–2025

206
Papers
35,093
Citations
97
h-index
196
i10-index

Citations

Citations per year for Fernando C. Fervenza1994: 4 citations2002: 3 citations2003: 6 citations2004: 14 citations2005: 19 citations2006: 28 citations2007: 14 citations2008: 32 citations2009: 37 citations2010: 56 citations2011: 117 citations2012: 183 citations2013: 217 citations2014: 194 citations2015: 258 citations2016: 264 citations2017: 213 citations2018: 274 citations2019: 911 citations2020: 1,118 citations2021: 1,119 citations2022: 997 citations2023: 1,016 citations2024: 1,618 citations2025: 755 citations2026: 16 citations1995–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,991 citing papers, 20.8% of this breakdownChina: 1,020 citing papers, 10.7% of this breakdownUnited Kingdom: 744 citing papers, 7.8% of this breakdownItaly: 569 citing papers, 5.9% of this breakdownFrance: 530 citing papers, 5.5% of this breakdownGermany: 507 citing papers, 5.3% of this breakdownNetherlands: 373 citing papers, 3.9% of this breakdownCanada: 364 citing papers, 3.8% of this breakdownSpain: 313 citing papers, 3.3% of this breakdownJapan: 310 citing papers, 3.2% of this breakdownAustralia: 253 citing papers, 2.6% of this breakdownSweden: 184 citing papers, 1.9% of this breakdown
0%20.8%Other 25.3%

Fields

  • Medicine78.1%
  • Immunology and Microbiology9.6%
  • Biochemistry, Genetics and Molecular Biology9.3%
  • Computer Science1.5%
  • Engineering0.3%
  • Environmental Science0.2%
  • Other1%

Topics

  • Renal Diseases and Glomerulopathies14.6%
  • Vasculitis and related conditions8.7%
  • Chronic Kidney Disease and Diabetes6.7%
  • Systemic Lupus Erythematosus Research4.7%
  • Complement system in diseases3.9%
  • Amyloidosis: Diagnosis, Treatment, Outcomes2.5%
  • Other58.9%

Coauthors

All papers

Open in search
  1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2021 cited by 2,416

  2. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 cited by 791

  3. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Authors: , , , , , , , , , , , - Arthritis & Rheumatism 2012 cited by 1,437

  4. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,726

  5. Membranous nephropathy

    Authors: , , , , , , , , , - Nature Reviews Disease Primers 2021 cited by 460

  6. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran - New England Journal of Medicine 2019 cited by 600

  7. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eduardo Verde, Eduardo Gutiérrez, Enyu Imai, Fan Fan Hou, Fernando Caravaca, Fernando C. Fervenza, Francesco Locatelli, Francesco Paolo Schena, Fumiaki Kobayashi, Gabriella Moroni, Gavin J. Becker, Gerald J. Beck, Gerald B. Appel, Gershon Frisch, GG van Essen, Giuseppe Maschio, Giuseppe Remuzzi, Giuseppe Montogrino, Hans‐Henrik Parving, Hiddo J.L. Heerspink, Hirofumi Makino, Imitiaz Jehan, Jack F.M. Wetzels, James V. Donadío, Jamie P. Dwyer, Jan A.J.G. van den Brand, John W. Kusek, John M. Lachin, José Luño, Julia B. Lewis, Jürgen Floege, Kaleab Z. Abebe, K.-M. Chow, Lawrence G. Hunsicker, Lucia Del Vecchio, Manno Carlo, Manuel Praga, Marián Goicoechea, Maximilian von Eynatten, Neil Poulter, Nish Chaturvedi, Patrizia Passerini, Paul E. de Jong, Peter J. Blankestijn, Philip H. Li, Piero Ruggenenti, P Zucchelli, Priscilla Kincaid‐Smith, R.-D Hilgers, Raymond O. Estacio, Richard D. Rohde, Ritsuko Katafuchi, Robert D. Toto, Robert W. Schrier, Roger A. Rodby, Ronald D. Perrone, Sadayoshi Ito, Saulo Klahr, Simeone Andrulli, Svend Strandgaard, Tak Mao Chan, Thierry Hannedouche, Thomas Rauen, Tom Greene, Úrsula Verdalles, Vlado Perkovic, William F. Keane - The Lancet Diabetes & Endocrinology 2019 cited by 372

  8. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Chi Bon Leung, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang - Kidney International 2009 cited by 1,236

  9. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 288

  10. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel - Kidney International 2016 cited by 695

  11. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

    Authors: , , , , , , , , , , - Kidney International 2019 cited by 353

  12. C3 glomerulopathy: consensus report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen-Chao Song, Paul P. Tamburini, Joshua M. Thurman, Michael Zavros, H. Terence Cook - Kidney International 2013 cited by 641

  13. Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John H. Stone - New England Journal of Medicine 2013 cited by 727

  14. Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sharon G. Adler, Cynthia C. Nast, Janine LaPage, John H. Stroger, Ambarish M. Athavale, M. Itteera, Alicia M. Neu, Sara Ashley Boynton, Fernando C. Fervenza, Marie C. Hogan, John C. Lieske, Vladimir Chernitskiy, Frederick J. Kaskel, Navdeep Kumar, P. Flynn, Jeffrey B. Kopp, J. Thomas Blake, Howard Trachtman, Olga Zhdanova, Frank Modersitzki, Sandro Vento, Richard Lafayette, K. Mehta, Crystal A. Gadegbeku, Duncan B. Johnstone, S. Quinn-Boyle, D C Cattran, Michelle Hladunewich, Heather N. Reich, P. Ling, Martin Romano, Alessia Fornoni, Carlos Bidot, Matthias Kretzler, Debbie S. Gipson, Alex E D Williams, Jeffrey R. Lavigne, Vimal K. Derebail, Keisha L. Gibson, A. Froment, S. Grubbs, Lawrence B. Holzman, Kevin Meyers, K. Kallem, J. Lalli, Kamalanathan K. Sambandam, Z. Wang, M. Rogers, A. Jefferson, Sangeeta Hingorani, Katherine R. Tuttle, Mark‐Anthony Bray, Molly L. Kelton, Ann Cooper, Benjamin Freedman, J.J. Lin - Kidney International 2020 cited by 194

  15. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agnieszka Perkowska‐Ptasińska, Magdalena Durlik, Krzysztof Mucha, Barbara Moszczuk, Bartosz Foroncewicz, Leszek Pączek, Ireneusz Habura, Elisabet Ars, José Ballarín, Laila-Yasmin Mani, Bruno Vogt, Savaş Öztürk, Abdülmecit Yıldız, Nurhan Seyahi, Hakkı Arikan, Mehmet Koç, Taner Baştürk, Gonca E. Karahan, Sebahat Usta Akgül, Mehmet Şükrü Sever, Dan Zhang, Domenico Santoro, Mario Bonomini, Francesco Londrino, Loreto Gesualdo, Jana Reiterová, Vladimı́r Tesař, Claudia Izzi, Silvana Savoldi, Donatella Spotti, Carmelita Marcantoni, Piergiorgio Messa, Marco Galliani, Dario Roccatello, Simona Granata, Gianluigi Zaza, Francesca Lugani, Gian Marco Ghiggeri, Isabella Pisani, Landino Allegri, Ben Sprangers, Jin‐Ho Park, Belong Cho, Yon Su Kim, Dong Ki Kim, Hitoshi Suzuki, Antonio Amoroso, Daniel Cattran, Fernando C. Fervenza, Antonello Pani, Patrick Hamilton, Shelly Harris, Sanjana Gupta, Chris Cheshire, Stephanie Dufek, Naomi Issler, Ruth J. Pepper, John Connolly, Stephen H. Powis, Detlef Böckenhauer, Horia Stanescu, Neil Ashman, Ruth J. F. Loos, Eimear E. Kenny, Matthias Wuttke, Kai‐Uwe Eckardt, Anna Köttgen, Julia M. Hofstra, Marieke J. H. Coenen, Lambertus A. Kiemeney and 20 more - Nature Communications 2020 cited by 220

  16. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonello Pani, Manuel Praga, Giuseppe Remuzzi, Helmut G. Rennke, Piero Ruggenenti, Dario Roccatello, María José Soler, Ulrich Specks, Rolf A.K. Stahl, Raman Deep Singh, Jason D. Theis, Jorge A. Velosa, Jack F.M. Wetzels, Christopher G. Winearls, Federico Yandián, Ladan Zand, Pierre Ronco, Fernando C. Fervenza - Kidney International 2023 cited by 113

  17. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr - Nature Reviews Nephrology 2018 cited by 534

  18. Exostosin 1/Exostosin 2–Associated Membranous Nephropathy

    Authors: , , , , , , , , , - Journal of the American Society of Nephrology 2019 cited by 304

  19. Protocadherin 7–Associated Membranous Nephropathy

    Authors: , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 161

  20. Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases

    Authors: , , - American Journal of Kidney Diseases 2020 cited by 105

  21. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia C. Nast, Alicia M. Neu, Heather N. Reich, John R. Sedor, Christine B. Sethna, Howard Trachtman, Katherine R. Tuttle, Olga Zhdanova, Gastón E. Zilleruelo, Matthias Kretzler - Kidney International 2013 cited by 350

  22. Pirfenidone for Diabetic Nephropathy

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2011 cited by 312

  23. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce A. Julian, Tetsuya Kawamura, Fernand Mac–Moune Lai, Lei-Shi Li, Philip Kam‐Tao Li, Zhi-Hong Liu, Bruce Mackinnon, Sergio Mezzano, Francesco Paolo Schena, Yasuhiko Tomino, Patrick D. Walker, Haiyan Wang, Jan J. Weening, Nori Yoshikawa, Hong Zhang - Kidney International 2009 cited by 1,040

  24. A proposal for standardized grading of chronic changes in native kidney biopsy specimens

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2017 cited by 276